ZYDUS PHARMACEUTICALS USA H-1B Visa Sponsorship & Salary Data

The median H-1B salary at ZYDUS PHARMACEUTICALS USA is $121,516, based on 20 certified filings from FY 2020 to FY 2026. This is 1% higher than the national H-1B median salary of $120,000. Compensation at ZYDUS PHARMACEUTICALS USA reflects their market positioning, with entry-level roles starting around $87,000 and senior positions reaching $203,148 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at ZYDUS PHARMACEUTICALS USA range from $70,100 at the 10th percentile to $203,148 at the 90th percentile, showing a $133,048 spread across experience levels and roles. The 25th percentile is $87,000 and the 75th percentile is $158,250.

Yes, ZYDUS PHARMACEUTICALS USA actively sponsors H-1B visas in FY 2026. In the most recent fiscal year (FY 2026), ZYDUS PHARMACEUTICALS USA filed 4 H-1B labor condition applications with 4 certified and 0 denied, at a median salary of $150,000. Across FY 2020–2026, they have filed 23 total H-1B applications with 20 certified and a 0% lifetime denial rate, demonstrating ongoing commitment to hiring international talent. ZYDUS PHARMACEUTICALS USA sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2026), ZYDUS PHARMACEUTICALS USA filed 4 H-1B applications, with 4 certified and 0 denied. Over 7 years of data, ZYDUS PHARMACEUTICALS USA has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

ZYDUS PHARMACEUTICALS USA's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 23 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating ZYDUS PHARMACEUTICALS USA as a potential H-1B sponsor.

This is an excellent approval rate, indicating ZYDUS PHARMACEUTICALS USA has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

ZYDUS PHARMACEUTICALS USA sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 20 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles ZYDUS PHARMACEUTICALS USA most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at ZYDUS PHARMACEUTICALS USA:

The most frequently sponsored role is Assoc. Director IT Delivery Mgmt-Infrastructure & Commercial with 2 filings at a median salary of $160,000. This is followed by Manager, Accounts Payable (2 filings) and Drug Safety Associate.

ZYDUS PHARMACEUTICALS USA's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where ZYDUS PHARMACEUTICALS USA sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top ZYDUS PHARMACEUTICALS USA H-1B locations:

The largest H-1B hub for ZYDUS PHARMACEUTICALS USA is Pennington, NJ with 20 filings at a median salary of $121,516.

ZYDUS PHARMACEUTICALS USA's median H-1B salary has increased by +23% from FY 2020 ($121,516) to FY 2026 ($150,000). Tracking salary trends over time reveals how ZYDUS PHARMACEUTICALS USA adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at ZYDUS PHARMACEUTICALS USA.

Year-by-year breakdown:

• FY 2022: $80,000 (2 certified)
• FY 2023: $158,250 (3 certified)
• FY 2024: $137,000 (2 certified)
• FY 2025: $115,000 (2 certified)
• FY 2026: $150,000 (4 certified)

This 23% growth reflects strong compensation adjustments at ZYDUS PHARMACEUTICALS USA, keeping pace with market demands for H-1B talent.

ZYDUS PHARMACEUTICALS USA primarily files H-1B applications at Wage Level II, accounting for 45% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making ZYDUS PHARMACEUTICALS USA's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

ZYDUS PHARMACEUTICALS USA has a mix of entry-level (Level I) and experienced (Level II+) H-1B positions. This reflects a range of roles from junior to senior.

ZYDUS PHARMACEUTICALS USA's median H-1B salary of $121,516 is 1% higher than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating ZYDUS PHARMACEUTICALS USA's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare ZYDUS PHARMACEUTICALS USA's offerings with similar companies in your field for a more accurate assessment.

ZYDUS PHARMACEUTICALS USA offers above-average H-1B compensation. Combined with their 20 certified filings and 0% denial rate, they demonstrate solid H-1B sponsorship practices.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. ZYDUS PHARMACEUTICALS USA files 30% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 20 certified filings, ZYDUS PHARMACEUTICALS USA invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.